Bonraybio

TPE-6955
Taiwan Stock Exchange
Electromedical and Electrotherapeutic Apparatus
Global Rank
#22967
Country Rank
#1121
Market Cap
128.94 M
Price
5.09
Change (%)
3.51%
Volume
24,746

Bonraybio's latest marketcap:

128.94 M

As of 07/06/2025, Bonraybio's market capitalization has reached $128.94 M. According to our data, Bonraybio is the 22967th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 128.94 M
Revenue (ttm) 7.29 M
Net Income (ttm) 1.91 M
Shares Out 19.65 M
EPS (ttm) 0.1
Forward PE 0.00
Ex-Dividend Date 03/27/2025
Earnings Date 08/08/2025
Market Cap Chart
Data Updated: 07/06/2025

Bonraybio's yearly market capitalization.

Bonraybio has seen its market value drop from NT$1.47 B to NT$128.94 M since 2023, representing a total decrease of 91.22% and an annual compound decline rate (CAGR) of 79.81%.
Date Market Cap Change (%) Global Rank
07/06/2025 NT$128.94 M 25.25% 22967
12/31/2024 NT$2.96 B 101.25% 23949
12/29/2023 NT$1.47 B 28061

Company Profile

About Bonraybio Co., Ltd.

Bonraybio Co., Ltd. is a development-stage company specializing in medical instruments and solutions for the male infertility market. Founded in 2015 and headquartered in Taichung, Taiwan, the company focuses on innovative diagnostic tools and consumables.

Key Products and Solutions

  • LensHooke X12 PRO – Semen analysis systems
  • LensHooke X1 PRO – Semen quality analyzers

Consumables

  • CS3 – Semen test slides
  • CA0/CA1 – Sperm separation solutions
  • CS1 – Semen test cassettes

Additional Offerings

  • X QC Reticles, X QC Video Tools, and X QC Beads – Quality control solutions
  • Sperm DNA Fragmentation Test Kits – Advanced diagnostic tools
  • S10 Data Consolidation Software – Streamlined data management

Frequently Asked Questions

  • What is Bonraybio's (TPE-6955) current market cap?
    As of 07/06/2025, Bonraybio (including the parent company, if applicable) has an estimated market capitalization of $128.94 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Bonraybio global market capitalization ranking is approximately 22967 as of 07/06/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.